166 related articles for article (PubMed ID: 19460565)
1. Orthotopic liver transplantation after successful treatment with anti-CD20 monoclonal antibody (rituximab) for severe steroid-resistant autoimmune hemolytic anemia: a case report.
Annicchiarico BE; Siciliano M; Avolio AW; Agnes S; Bombardieri G
Transplant Proc; 2009 May; 41(4):1380-2. PubMed ID: 19460565
[TBL] [Abstract][Full Text] [Related]
2. [Anti-CD20 monoclonal antibody for the treatment of refractory autoimmune hemolytic anemia].
Wang L; Xu W; Li JY; Xie XY; Sheng RL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):425-8. PubMed ID: 17493362
[TBL] [Abstract][Full Text] [Related]
3. Anti-CD20 treatment of giant cell hepatitis with autoimmune hemolytic anemia.
Paganelli M; Patey N; Bass LM; Alvarez F
Pediatrics; 2014 Oct; 134(4):e1206-10. PubMed ID: 25201797
[TBL] [Abstract][Full Text] [Related]
4. Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.
D'Arena G; Laurenti L; Capalbo S; D'Arco AM; De Filippi R; Marcacci G; Di Renzo N; Storti S; Califano C; Vigliotti ML; Tarnani M; Ferrara F; Pinto A
Am J Hematol; 2006 Aug; 81(8):598-602. PubMed ID: 16823816
[TBL] [Abstract][Full Text] [Related]
5. Livedo reticularis associated with autoimmune hemolytic anemia: prolonged remission induced by peripheral blood stem cell transplantation relapse after 10 years and restoration of hemoglobin levels by rituximab.
Ferreira E; Feitosa A; Hamerschlak N; Scheinberg MA
Rev Bras Reumatol; 2012; 52(1):122-4. PubMed ID: 22286652
[TBL] [Abstract][Full Text] [Related]
6. Sustained response to low-dose rituximab in idiopathic autoimmune hemolytic anemia.
Barcellini W; Zaja F; Zaninoni A; Imperiali FG; Di Bona E; Fattizzo B; Consonni D; Cortelezzi A; Zanella A
Eur J Haematol; 2013 Dec; 91(6):546-51. PubMed ID: 24033754
[TBL] [Abstract][Full Text] [Related]
7. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
[TBL] [Abstract][Full Text] [Related]
8. Severe hemolytic anemia due to cold agglutinin complicating untreated chronic hepatitis C: efficacy and safety of anti-CD20 (rituximab) treatment.
Etienne A; Gayet S; Vidal F; Poullin P; Brunet C; Harlé JR; Kaplanski G
Am J Hematol; 2004 Apr; 75(4):243-5. PubMed ID: 15054819
[TBL] [Abstract][Full Text] [Related]
9. Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient.
Gentile M; Lucia E; Iorio C; Vigna E; Mazzone C; Morelli R; Bisconte MG; Gentile C; Morabito F
Cancer Chemother Pharmacol; 2008 Sep; 62(4):741-3. PubMed ID: 18064461
[TBL] [Abstract][Full Text] [Related]
10. [Successful treatment with rituximab in a patient with refractory mixed-type autoimmune hemolytic anemia].
Ono K; Sato T; Iyama S; Tatekoshi A; Hashimoto A; Kamihara Y; Horiguchi H; Kikuchi S; Takada K; Hayashi T; Miyanishi K; Sato Y; Takimoto R; Kobune M; Kato J
Rinsho Ketsueki; 2013 Nov; 54(11):2053-5. PubMed ID: 24305538
[TBL] [Abstract][Full Text] [Related]
11. Sustained response to rituximab of autoimmune hemolytic anemia associated with antiphospholipid syndrome.
Erdozain JG; Ruiz-Irastorza G; Egurbide MV; Aguirre C
Haematologica; 2004 Sep; 89(9):ECR34. PubMed ID: 15377486
[TBL] [Abstract][Full Text] [Related]
12. Anti-CD20 monoclonal antibody (Rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus.
Perrotta S; Locatelli F; La Manna A; Cennamo L; De Stefano P; Nobili B
Br J Haematol; 2002 Feb; 116(2):465-7. PubMed ID: 11841453
[TBL] [Abstract][Full Text] [Related]
13. End-stage liver cirrhosis with severe autoimmune hemolytic anemia, treated by blood type-incompatible living donor liver transplantation: a case report.
Sanefuji K; Ikegami T; Nagata S; Sugimachi K; Gion T; Uchiyama H; Soejima Y; Taketomi A; Shirabe K; Maehara Y
Transplant Proc; 2011 Jun; 43(5):2087-9. PubMed ID: 21693332
[TBL] [Abstract][Full Text] [Related]
14. Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia.
Gupta N; Kavuru S; Patel D; Janson D; Driscoll N; Ahmed S; Rai KR
Leukemia; 2002 Oct; 16(10):2092-5. PubMed ID: 12357362
[TBL] [Abstract][Full Text] [Related]
15. Rituximab for warm-type idiopathic autoimmune hemolytic anemia: a retrospective study of 11 adult patients.
D'Arena G; Califano C; Annunziata M; Tartarone A; Capalbo S; Villani O; Amendola G; Pietrantuono G; Ferrara F; Pinto A; Musto P; D'Arco AM; Cascavilla N
Eur J Haematol; 2007 Jul; 79(1):53-8. PubMed ID: 17532766
[TBL] [Abstract][Full Text] [Related]
16. [Successful treatment with rituximab for autoimmune hemolytic anemia associated with chronic lymphocytic leukemia].
Tanaka Y; Ito Y; Yoshizawa S; Fujimoto H; Gotoh M; Tauchi T; Kimura Y; Ohyashiki K
Rinsho Ketsueki; 2013 Feb; 54(2):229-31. PubMed ID: 23470833
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune hemolytic anemia with giant cell hepatitis: case report and review of the literature.
Gorelik M; Debski R; Frangoul H
J Pediatr Hematol Oncol; 2004 Dec; 26(12):837-9. PubMed ID: 15591908
[TBL] [Abstract][Full Text] [Related]
18. Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody).
Karlsson C; Hansson L; Celsing F; Lundin J
Leukemia; 2007 Mar; 21(3):511-4. PubMed ID: 17215854
[TBL] [Abstract][Full Text] [Related]
19. Brucellosis-induced autoimmune hemolytic anemia treated with rituximab.
Bourantas LK; Pappas G; Kapsali E; Gougopoulou D; Papamichail D; Bourantas KL
Ann Pharmacother; 2010 Oct; 44(10):1677-80. PubMed ID: 20823278
[TBL] [Abstract][Full Text] [Related]
20. Rituximab for refractory childhood autoimmune hemolytic anemia.
Motto DG; Williams JA; Boxer LA
Isr Med Assoc J; 2002 Nov; 4(11):1006-8. PubMed ID: 12489491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
